Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal recessive nonsyndromic deafness in which the cause of the disease is a mutation in the CLDN14 gene.
Features include: Hearing loss (hearing impairment) and Inner ear hearing loss (sensorineural hearing impairment).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 2 | Hearing loss (hearing impairment), Inner ear hearing loss (sensorineural hearing impairment) |
CLDN14 encodes claudin 14 (239 aa). Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity Highest expression in Liver (12.9 TPM) and Kidney Medulla (9.1 TPM).
Autosomal recessive nonsyndromic hearing loss 29 is associated with mutations in the CLDN14 gene on chromosome 21.
CLDN14 is classified as a druggable target with score 0.0.
Genetic testing for CLDN14 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for autosomal recessive nonsyndromic hearing loss 29 has been reported in the published literature.
No clinical trials have been registered for autosomal recessive nonsyndromic hearing loss 29.
10 publications have been identified in PubMed for autosomal recessive nonsyndromic hearing loss 29. Research spans Case Report / Case Series (50%), Epidemiology / Natural History (20%), and Diagnostic / Biomarker (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 5 | 50% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 4:50 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Disease patterns and progression
2 |
20% |
Testing and diagnosis research | 1 | 10% |
Laboratory research | 1 | 10% |
New treatment approaches | 1 | 10% |
Trilla P (2026). [PMID: 41758270](https://pubmed.ncbi.nlm.nih.gov/41758270/). *Cellular and molecular neurobiology*. [Case Report / Case Series]
Guan RR (2026). [PMID: 41521852](https://pubmed.ncbi.nlm.nih.gov/41521852/). *Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery*. [Case Report / Case Series]
Long X (2025). [PMID: 40410890](https://pubmed.ncbi.nlm.nih.gov/40410890/). *Human genomics*. [Basic Science / Preclinical]
Redfield SE (2025). [PMID: 40248902](https://pubmed.ncbi.nlm.nih.gov/40248902/). *American journal of medical genetics. Part C, Seminars in medical genetics*. [Gene Therapy / Novel Therapeutics]
Ding Y (2025). [PMID: 40195191](https://pubmed.ncbi.nlm.nih.gov/40195191/). *European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery*. [Diagnostic / Biomarker]
D'Arco F (2024). [PMID: 38833161](https://pubmed.ncbi.nlm.nih.gov/38833161/). *Neuroradiology*. [Epidemiology / Natural History]
Demirtaş B (2024). [PMID: 39128043](https://pubmed.ncbi.nlm.nih.gov/39128043/). *The journal of international advanced otology*. [Case Report / Case Series]
Tlili A (2024). [PMID: 38790217](https://pubmed.ncbi.nlm.nih.gov/38790217/). *Genes*. [Case Report / Case Series]
Antunes LN (2024). [PMID: 39498320](https://pubmed.ncbi.nlm.nih.gov/39498320/). *Frontiers in genetics*. [Epidemiology / Natural History]
Holanda IP (2024). [PMID: 38674450](https://pubmed.ncbi.nlm.nih.gov/38674450/). *Genes*. [Case Report / Case Series]